Sunshine Biopharma Inc. Debt, Weighted Average Interest Rate
Sunshine Biopharma Inc. (SBFM) had Debt, Weighted Average Interest Rate of 12.00% as of 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtWeightedAverageInterestRate · last filed 2012-11-08
- 2012-09-30: Debt, Weighted Average Interest Rate 12.00%.
- 2012-06-30: Debt, Weighted Average Interest Rate 12.00%.
| Period end | Debt, Weighted Average Interest Rate |
|---|---|
| 2012-09-30 | 12.00% 10-Q · filed 2012-11-08 |
| 2012-06-30 | 12.00% 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |